St. Jude Medical
St. Jude Medical announced the launch of its third randomized clinical trial to compare the company's optical coherence tomography imaging to intravascular ultrasound and angiography alone. The three imaging systems will square off as a guide to stent implantation, which occurs during percutaneous coronary intervention procedures.
Medtronic reports early pivotal data for tiny leadless pacemaker with U.S. launch slated in a year or so
Cardiac Rhythm & Heart Failure is one of Medtronic's faster growing businesses, driven in part by the launch of tiny subcutaneous heart monitor Reveal Linq. The medical device giant expects that the launch of supersmall leadless pacemaker Micra Transcatheter Pacing System could help it to keep that revenue growth momentum going.
St. Jude Medical just received the FDA's coveted PMA approval for its Brio Neurostimulator System to treat the symptoms of Parkinson's and essential tremor. Brio joins Medtronic's Activa as the second deep-brain stimulation device on the market for those conditions.
St. Jude gains CE mark for first app-based pain neuromodulation patient trial system for use ahead of implant
Major medical device makers haven't exactly rushed to integrate smartphones and tablets into their product lineups, despite their ubiquity and obvious potential medical utility. But now St. Jude Medical has gained a CE mark and launched the first app-based, wireless system for use during an initial patient trial period with an external neuromodulation chronic pain treatment device prior to receiving a permanent implant.
St. Jude Medical got FDA approval to resume a U.S. trial of its transcatheter aortic valve system, a win for the company as it recovers from safety concerns tied to the device last year.
St. Jude Medical suffered a rare withdrawal of the CE mark of its Portico transaortic aortic valve replacement last year and had to suspend its U.S. clinical trial for FDA approval. Now new data released from three studies at the annual EuroPCR conference in Paris should help St. Jude convince the FDA to resume that trial.
St. Jude Medical highlighted studies that demonstrate the effectiveness of optical coherence tomography during stenting procedures at the EuroPCR conference in Paris.
St. Jude Medical said in a new study that its CardioMEMS HF System can deliver improved outcomes and be cost-effective for heart failure patients who are already well-managed for their condition when they use pulmonary artery pressure monitoring.
Study: Remote monitoring of cardiac device patients results in better survival, less hospitalization
Tracking patients who have various cardiac devices via a remote monitoring system cuts down on hospitalizations and costs, while improving patient survival. That's according to a 5-year study by St. Jude Medical of more than 90,000 patients with pacemakers, implantable cardioverter defibrillators, and cardiac resynchronization therapy devices.
St. Jude gets FDA approval for tiniest MRI-compatible, upgradeable, spinal-cord pain neurostimulator
The FDA has approved the Protégé MRI spinal cord stimulation system to treat chronic pain, along with the related MRI compatible leads, from St. Jude Medical. The device also offers the benefit of enabling future updates via wireless software upgrades rather than requiring its replacement to gain the benefits of new developments.